drugset / Trial / NCT03361774

A Clinical Method Development Study to Characterise The Efficacy of a Dentifrice For The Relief Of Dentin Hypersensitivity

NCT03361774

Phase 2 Withdrawn GlaxoSmithKline
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study is to develop the clinical methodology to characterize the efficacy profiles of an experimental 5% potassium nitrate (KNO3) and 0.454% stannous fluoride (SnF2) combination dentifrice and a marketed desensitizing 0.454% SnF2 only dentifrice for the relief of dentin hypersensitivity (DH), at multiple time points, over an 8 week treatment period.

Timeline

Start
2018-10-01
Primary completion
2018-12-03
Completion
2018-12-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Potassium Nitrate Other / unclassified 5 %
Subject stannous fluoride Small molecule 0.454 %

Indications